Veradermics (MANE) Profit After Tax (2025 - 2026)
Veradermics' (MANE) quarterly Profit After Tax came in at -$584000.0 in Q1 2026, up 96.0% YoY from -$297966.7 in Q1 2025, and up 96.0% on a QoQ basis from -$14.6 million in Q1 2025.
Powered by 
Analysis
Veradermics (MANE) Profit After Tax (2025 - 2026) Analysis & Trends
Veradermics (MANE) has 2 years of Profit After Tax data on file, last reported at -$584000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Veradermics | 3.96 Bn | 3.96 Bn | - | -23.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.87 Mn |
| Mar 31, 2026 | -27.23 Mn |
| Jun 30, 2025 | -18.01 Mn |
| Mar 31, 2025 | -12.40 Mn |